🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial is studying sorafenib tosylate and gene expression in p...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2006-12
Trial ID
NCT00466752
Different subtypes of serrated lesions have been recently described. Among ...
Status
Active Not Recruiting
Location
Hospital Universitari i Politècnic La Fe
Start Date
2017-06-01
Trial ID
NCT03089268
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615
This is a randomized control trial of patients with suspected malignant ple...
Status
Recruiting
Location
Mount Sinai West
Start Date
2025-03-24
Trial ID
NCT06892691
Treatments Being Tested
The aim of the study is to evaluate toxicity and effectiveness of electroch...
Status
Completed
Location
Institute of Oncology Ljubljana
Start Date
2008-11
Trial ID
NCT01264952
Treatments Being Tested
In this preliminary study, we propose that the intraepidermic injection of ...
Status
Completed
Location
Entertainment Area, Badr City, Cairo, Egypt
Start Date
2018-01-03
Trial ID
NCT07043985
Treatments Being Tested
Acute kidney injury (AKI) has been traditionally defined as an abrupt loss ...
Status
Unknown
Location
Sohag General Hospital
Start Date
2022-01-01
Trial ID
NCT05297214
Treatments Being Tested
Pancreatic cancer is a lethal disease. The 1-year and 5-year survival rate ...
Status
Terminated
Location
Oxford University Hospitals NHS Foundation Trust
Start Date
2018-07-02
Trial ID
NCT03531125
Treatments Being Tested
RATIONALE: Testing for minimal residual disease in cell samples from patien...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01533168
This phase I trial tests the safety, side effects, best dose of MUC1-activa...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-09-20
Trial ID
NCT06483048